Christopher Degiorgio • UCLA Profiles (original) (raw)

  1. Is Cardiovascular Mortality Among People with Epilepsy increasing? A retrospective US population study. BMJ Open. 2025 Nov 28; 15(11):e095195. Curtis A, Markovic D, Liao A, Ganapa S, Gaertner M, DeGiorgio CM. PMID: 41314834; PMCID: PMC12666228.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  2. Oxygen-15 Labeled Water Positron Emission Tomography During External Trigeminal Nerve Stimulation. Neuromodulation. 2025 Dec; 28(8):1265-1273. DeGiorgio CM, Schrader LM, Miller P, Susselman MK, Geist CL, Cook IA, Silverman D. PMID: 41108302.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  3. Should neurologists initiate treatment for hypertension and hyperlipidemia to reduce cardiovascular risk in epilepsy? Front Neurol. 2023; 14:1268920. Gaertner M, DeGiorgio CM. PMID: 39027363; PMCID: PMC11254788.
    View in: PubMed Mentions: 1
  4. Increased cardiovascular risk in epilepsy. Front Neurol. 2024; 15:1339276. Gaertner ML, Mintzer S, DeGiorgio CM. PMID: 38633529; PMCID: PMC11021572.
    View in: PubMed Mentions: 7
  5. Prospective, Randomized Trial Comparing Simulator-based versus Traditional Teaching of Direct Ophthalmoscopy for Medical Students. Am J Ophthalmol. 2022 06; 238:187-196. Howell GL, Chávez G, McCannel CA, Quiros PA, Al-Hashimi S, Yu F, Fung S, DeGiorgio CM, Huang YM, Straatsma BR, Braddock CH, Holland GN. PMID: 34801508.
    View in: PubMed Mentions: 9 Fields:
    Translation:Humans
  6. SUDEP-7 Inventory: Validation in a retrospective cohort study. Epilepsia. 2021 11; 62(11):2871-2872. Kerr WT, Markovic D, DeGiorgio CM. PMID: 34545571.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  7. Changes in epilepsy causes of death: A US population study. Acta Neurol Scand. 2021 Nov; 144(5):478-485. DeGiorgio CM, Curtis AT, Hertling D, Kerr WT, Markovic D. PMID: 34268731.
    View in: PubMed Mentions: 7 Fields:
    Translation:Humans
  8. Why are epilepsy mortality rates rising in the United States? A population-based multiple cause-of-death study. BMJ Open. 2020 08 24; 10(8):e035767. DeGiorgio CM, Curtis A, Carapetian A, Hovsepian D, Krishnadasan A, Markovic D. PMID: 32839157; PMCID: PMC7449302.
    View in: PubMed Mentions: 28 Fields:
    Translation:Humans
  9. Editorial: Sudden Unexpected Death in Epilepsy: Bio-markers, Mechanisms, Risk Identification and Prevention. Front Neurol. 2019; 10:1277. Surges R, Sperling MR, DeGiorgio CM. PMID: 31866931; PMCID: PMC6904271.
    View in: PubMed Mentions: 3
  10. Safety and tolerability of Vitamin D3 5000 IU/day in epilepsy. Epilepsy Behav. 2019 05; 94:195-197. DeGiorgio CM, Hertling D, Curtis A, Murray D, Markovic D. PMID: 30970298.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  11. Sudden unexpected death in epilepsy: Risk factors, biomarkers, and prevention. Acta Neurol Scand. 2019 Mar; 139(3):220-230. DeGiorgio CM, Curtis A, Hertling D, Moseley BD. PMID: 30443951.
    View in: PubMed Mentions: 38 Fields:
    Translation:Humans
  12. MELAS: Monitoring treatment with magnetic resonance spectroscopy. Acta Neurol Scand. 2019 Jan; 139(1):82-85. Hovsepian DA, Galati A, Chong RA, Mazumder R, DeGiorgio CM, Mishra S, Yim C. PMID: 30216413.
    View in: PubMed Mentions: 10 Fields:
    Translation:Humans
  13. Editorial: Sudden Death in Epilepsy: Basic and Translational Research. Front Neurol. 2018; 9:484. DeGiorgio CM. PMID: 29997564; PMCID: PMC6030357.
    View in: PubMed Mentions: 3
  14. Ranking the Leading Risk Factors for Sudden Unexpected Death in Epilepsy. Front Neurol. 2017; 8:473. DeGiorgio CM, Markovic D, Mazumder R, Moseley BD. PMID: 28983274; PMCID: PMC5613169.
    View in: PubMed Mentions: 46
  15. Vitamin D3 for the Treatment of Epilepsy: Basic Mechanisms, Animal Models, and Clinical Trials. Front Neurol. 2016; 7:218. Pendo K, DeGiorgio CM. PMID: 28008324; PMCID: PMC5143473.
    View in: PubMed Mentions: 15
  16. Omega-3 fatty acids (ῳ-3 fatty acids) in epilepsy: animal models and human clinical trials. Expert Rev Neurother. 2016 10; 16(10):1141-5. DeGiorgio CM, Taha AY. PMID: 27534261.
    View in: PubMed Mentions: 14 Fields:
    Translation:HumansAnimals
  17. Risk Assessment for Sudden Death in Epilepsy: The SUDEP-7 Inventory. Front Neurol. 2015; 6:252. Novak JL, Miller PR, Markovic D, Meymandi SK, DeGiorgio CM. PMID: 26696953; PMCID: PMC4673971.
    View in: PubMed Mentions: 36
  18. Neuromodulation in the Treatment of Epilepsy. Curr Treat Options Neurol. 2015 Oct; 17(10):375. Nune G, DeGiorgio C, Heck C. PMID: 26307329.
    View in: PubMed Mentions: 21
  19. The SUDEP Risk Inventory: Association with postictal generalized EEG suppression. Epilepsy Res. 2015 Nov; 117:82-4. Moseley BD, DeGiorgio CM. PMID: 26425830.
    View in: PubMed Mentions: 16 Fields:
    Translation:Humans
  20. The potential use of trigeminal nerve stimulation in the treatment of epilepsy. Ther Deliv. 2015 Mar; 6(3):273-5. Cook IA, Kealey CP, DeGiorgio CM. PMID: 25853303.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  21. A prospective long-term study of external trigeminal nerve stimulation for drug-resistant epilepsy. Epilepsy Behav. 2015 Jan; 42:44-7. Soss J, Heck C, Murray D, Markovic D, Oviedo S, Corrale-Leyva G, Gordon S, Kealey C, DeGiorgio C. PMID: 25499162.
    View in: PubMed Mentions: 21 Fields:
    Translation:HumansCTClinical Trials
  22. Epilepsy & behavior: 15th anniversary research on omega-3 fatty acids for epilepsy. Epilepsy Behav. 2014 Nov; 40:124-5. DeGiorgio CM, Scorza FA. PMID: 25453552.
    View in: PubMed Mentions: 2 Fields:
    Translation:HumansAnimals
  23. Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study. J Neurol Neurosurg Psychiatry. 2015 Jan; 86(1):65-70. DeGiorgio CM, Miller PR, Harper R, Gornbein J, Schrader L, Soss J, Meymandi S. PMID: 25201887.
    View in: PubMed Mentions: 27 Fields:
    Translation:HumansCTClinical Trials
  24. Refractory status epilepticus treated with trigeminal nerve stimulation. Epilepsy Res. 2014 Mar; 108(3):600-3. Moseley BD, Degiorgio CM. PMID: 24439211.
    View in: PubMed Mentions: 7 Fields:
    Translation:Humans
  25. Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy Behav. 2013 Aug; 28(2):221-6. Cook IA, Schrader LM, Degiorgio CM, Miller PR, Maremont ER, Leuchter AF. PMID: 23773978.
    View in: PubMed Mentions: 27 Fields:
    Translation:Humans
  26. Neurostimulation for drug-resistant epilepsy. Continuum (Minneap Minn). 2013 Jun; 19(3 Epilepsy):743-55. DeGiorgio CM, Krahl SE. PMID: 23739108; PMCID: PMC4234052.
    View in: PubMed Mentions: 19 Fields:
    Translation:Humans
  27. Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology. 2013 Feb 26; 80(9):786-91. DeGiorgio CM, Soss J, Cook IA, Markovic D, Gornbein J, Murray D, Oviedo S, Gordon S, Corralle-Leyva G, Kealey CP, Heck CN. PMID: 23365066; PMCID: PMC3598453.
    View in: PubMed Mentions: 57 Fields:
    Translation:HumansCTClinical Trials
  28. Ventricular tachycardia associated with lacosamide co-medication in drug-resistant epilepsy. Epilepsy Behav Case Rep. 2013; 1:26-8. DeGiorgio AC, Desso TE, Lee L, DeGiorgio CM. PMID: 25688050; PMCID: PMC4150657.
    View in: PubMed Mentions: 7
  29. Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression. Neurosurg Clin N Am. 2011 Oct; 22(4):449-56, v. DeGiorgio CM, Fanselow EE, Schrader LM, Cook IA. PMID: 21939843.
    View in: PubMed Mentions: 24 Fields:
    Translation:HumansAnimals
  30. Acute and long-term safety of external trigeminal nerve stimulation for drug-resistant epilepsy. Epilepsy Behav. 2011 Nov; 22(3):574-6. Pop J, Murray D, Markovic D, DeGiorgio CM. PMID: 21959083.
    View in: PubMed Mentions: 20 Fields:
    Translation:HumansCTClinical Trials
  31. Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial. Epilepsy Behav. 2011 Nov; 22(3):475-8. Schrader LM, Cook IA, Miller PR, Maremont ER, DeGiorgio CM. PMID: 21820361.
    View in: PubMed Mentions: 21 Fields:
    Translation:HumansCTClinical Trials
  32. Sudden unexpected death in epilepsy associated with progressive deterioration in heart rate variability. Epilepsy Behav. 2011 May; 21(1):103-5. Rauscher G, DeGiorgio AC, Miller PR, DeGiorgio CM. PMID: 21482484.
    View in: PubMed Mentions: 9 Fields:
    Translation:Humans
  33. RMSSD, a measure of vagus-mediated heart rate variability, is associated with risk factors for SUDEP: the SUDEP-7 Inventory. Epilepsy Behav. 2010 Sep; 19(1):78-81. DeGiorgio CM, Miller P, Meymandi S, Chin A, Epps J, Gordon S, Gornbein J, Harper RM. PMID: 20667792; PMCID: PMC2943000.
    View in: PubMed Mentions: 109 Fields:
    Translation:Humans
  34. Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures. Epilepsy Behav. 2010 Jul; 18(3):322-4. Degiorgio CM. PMID: 20570216.
    View in: PubMed Mentions: 23 Fields:
    Translation:Humans
  35. SUDEP and heart rate variability. Epilepsy Res. 2010 Aug; 90(3):309-10; author reply 311-2. DeGiorgio CM, DeGiorgio AC. PMID: 20399076; PMCID: PMC2989212.
    View in: PubMed Mentions: 7 Fields:
    Translation:Humans
  36. Trigeminal nerve stimulation for epilepsy: long-term feasibility and efficacy. Neurology. 2009 Mar 10; 72(10):936-8. DeGiorgio CM, Murray D, Markovic D, Whitehurst T. PMID: 19273830.
    View in: PubMed Mentions: 28 Fields:
    Translation:Humans
  37. n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study. Epilepsy Behav. 2008 Nov; 13(4):681-4. DeGiorgio CM, Miller P, Meymandi S, Gornbein JA. PMID: 18721899.
    View in: PubMed Mentions: 18 Fields:
    Translation:Humans
  38. n-3 fatty acids (eicosapentanoic and docosahexanoic acids) in epilepsy and for the prevention of sudden unexpected death in epilepsy. Epilepsy Behav. 2008 Nov; 13(4):712-3. DeGiorgio CM, Miller P. PMID: 18634902.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  39. Vagus nerve stimulation for epilepsy: is output current correlated with acute response? Acta Neurol Scand. 2007 Oct; 116(4):217-20. Bunch S, DeGiorgio CM, Krahl S, Britton J, Green P, Lancman M, Murphy J, Olejniczak P, Shih J, Heck CN. PMID: 17824897.
    View in: PubMed Mentions: 10 Fields:
    Translation:Humans
  40. Deaths from cysticercosis, United States. Emerg Infect Dis. 2007 Feb; 13(2):230-5. Sorvillo FJ, DeGiorgio C, Waterman SH. PMID: 17479884; PMCID: PMC2725874.
    View in: PubMed Mentions: 40 Fields:
    Translation:Humans
  41. Treatment of neurocysticercosis: current status and future research needs. Neurology. 2006 Oct 10; 67(7):1120-7. Nash TE, Singh G, White AC, Rajshekhar V, Loeb JA, Proaño JV, Takayanagui OM, Gonzalez AE, Butman JA, DeGiorgio C, Del Brutto OH, Delgado-Escueta A, Evans CA, Gilman RH, Martinez SM, Medina MT, Pretell EJ, Teale J, Garcia HH. PMID: 17030744; PMCID: PMC2923067.
    View in: PubMed Mentions: 62 Fields:
    Translation:Humans
  42. Pilot study of trigeminal nerve stimulation (TNS) for epilepsy: a proof-of-concept trial. Epilepsia. 2006 Jul; 47(7):1213-5. DeGiorgio CM, Shewmon A, Murray D, Whitehurst T. PMID: 16886985.
    View in: PubMed Mentions: 30 Fields:
    Translation:HumansCTClinical Trials
  43. Nitrous oxide inhalation as a cause of cervical myelopathy. Acta Neurol Scand. 2005 Oct; 112(4):270-2. Waters MF, Kang GA, Mazziotta JC, DeGiorgio CM. PMID: 16146499.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  44. Vagus nerve stimulation for epilepsy: randomized comparison of three stimulation paradigms. Neurology. 2005 Jul 26; 65(2):317-9. DeGiorgio C, Heck C, Bunch S, Britton J, Green P, Lancman M, Murphy J, Olejniczak P, Shih J, Arrambide S, Soss J. PMID: 16043810.
    View in: PubMed Mentions: 35 Fields:
    Translation:Humans
  45. Neurocysticercosis in the United States: review of an important emerging infection. Neurology. 2005 Apr 26; 64(8):1486; author reply 1486. DeGiorgio CM, Sorvillo F, Escueta SP. PMID: 15851761.
    View in: PubMed Mentions: 10 Fields:
    Translation:HumansAnimals
  46. Sero-prevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA. Acta Neurol Scand. 2005 Feb; 111(2):84-8. DeGiorgio C, Pietsch-Escueta S, Tsang V, Corral-Leyva G, Ng L, Medina MT, Astudillo S, Padilla N, Leyva P, Martinez L, Noh J, Levine M, del Villasenor R, Sorvillo F. PMID: 15644066.
    View in: PubMed Mentions: 25 Fields:
    Translation:HumansAnimals
  47. Neurocysticercosis. Epilepsy Curr. 2004 May-Jun; 4(3):107-11. DeGiorgio CM, Medina MT, Durón R, Zee C, Escueta SP. PMID: 16059465; PMCID: PMC1176337.
    View in: PubMed Mentions: 29
  48. Cysticercosis-related deaths, California. Emerg Infect Dis. 2004 Mar; 10(3):465-9. Sorvillo FJ, Portigal L, DeGiorgio C, Smith L, Waterman SH, Berlin GW, Ash LR. PMID: 15109414; PMCID: PMC3322784.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  49. Trigeminal nerve stimulation for epilepsy. Neurology. 2003 Aug 12; 61(3):421-2. DeGiorgio CM, Shewmon DA, Whitehurst T. PMID: 12913219.
    View in: PubMed Mentions: 23 Fields:
    Translation:HumansCTClinical Trials
  50. Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use. Neurology. 2002 Sep 24; 59(6 Suppl 4):S31-7. Heck C, Helmers SL, DeGiorgio CM. PMID: 12270966.
    View in: PubMed Mentions: 53 Fields:
    Translation:Humans
  51. Deaths associated with cysticercosis. Report of three cases and review of the literature. Neurosurg Focus. 2002 Jun 15; 12(6):e2. DeGiorgio CM, Houston I, Oviedo S, Sorvillo F. PMID: 15926781.
    View in: PubMed Mentions: 21 Fields:
    Translation:Humans
  52. Vagus nerve stimulation: analysis of device parameters in 154 patients during the long-term XE5 study. Epilepsia. 2001 Aug; 42(8):1017-20. DeGiorgio CM, Thompson J, Lewis P, Arrambide S, Naritoku D, Handforth A, Labar D, Mullin P, Heck C, VNS U.S. Study Group. PMID: 11554887.
    View in: PubMed Mentions: 24 Fields:
    Translation:HumansCTClinical Trials
  53. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia. 2000 Sep; 41(9):1195-200. DeGiorgio CM, Schachter SC, Handforth A, Salinsky M, Thompson J, Uthman B, Reed R, Collins S, Tecoma E, Morris GL, Vaughn B, Naritoku DK, Henry T, Labar D, Gilmartin R, Labiner D, Osorio I, Ristanovic R, Jones J, Murphy J, Ney G, Wheless J, Lewis P, Heck C. PMID: 10999559.
    View in: PubMed Mentions: 126 Fields:
    Translation:HumansCTClinical Trials
  54. Expression of neuron-specific enolase in adult rat brain following status epilepticus. Exp Neurol. 1999 Sep; 159(1):329-31. Schreiber SS, Sun N, Tocco G, Baudry M, DeGiorgio CM. PMID: 10486201.
    View in: PubMed Mentions: 5 Fields:
    Translation:Animals
  55. Experience with vagus nerve stimulation for intractable epilepsy: some questions and answers. Neurol Med Chir (Tokyo). 1999 Jul; 39(7):489-95. Amar AP, Heck CN, DeGiorgio CM, Apuzzo ML. PMID: 10437376.
    View in: PubMed Mentions: Fields:
    Translation:HumansCTClinical Trials
  56. Serum neuron-specific enolase in the major subtypes of status epilepticus. Neurology. 1999 Mar 10; 52(4):746-9. DeGiorgio CM, Heck CN, Rabinowicz AL, Gott PS, Smith T, Correale J. PMID: 10078721.
    View in: PubMed Mentions: 44 Fields:
    Translation:Humans
  57. Long-term multicenter experience with vagus nerve stimulation for intractable partial seizures: results of the XE5 trial. Stereotact Funct Neurosurg. 1999; 73(1-4):104-8. Amar AP, DeGiorgio CM, Tarver WB, Apuzzo ML. PMID: 10853111.
    View in: PubMed Mentions: 19 Fields:
    Translation:HumansCTClinical Trials
  58. An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique, and outcome. Neurosurgery. 1998 Dec; 43(6):1265-76; discussion 1276-80. Amar AP, Heck CN, Levy ML, Smith T, DeGiorgio CM, Oviedo S, Apuzzo ML. PMID: 9848840.
    View in: PubMed Mentions: 29 Fields:
    Translation:HumansAnimalsCTClinical Trials
  59. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology. 1998 Jul; 51(1):48-55. Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, Henry TR, Collins SD, Vaughn BV, Gilmartin RC, Labar DR, Morris GL, Salinsky MC, Osorio I, Ristanovic RK, Labiner DM, Jones JC, Murphy JV, Ney GC, Wheless JW. PMID: 9674777.
    View in: PubMed Mentions: 259 Fields:
    Translation:HumansCTClinical Trials
  60. Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier. Neurology. 1998 May; 50(5):1388-91. Correale J, Rabinowicz AL, Heck CN, Smith TD, Loskota WJ, DeGiorgio CM. PMID: 9595992.
    View in: PubMed Mentions: 26 Fields:
    Translation:Humans
  61. Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model. J Neurosurg. 1997 Nov; 87(5):731-7. Kittaka M, Giannotta SL, Zelman V, Correale JD, DeGiorgio CM, Weiss MH, Zlokovic BV. PMID: 9347982.
    View in: PubMed Mentions: 8 Fields:
    Translation:Animals
  62. Vagus nerve stimulation activates central nervous system structures in epileptic patients during PET H2(15)O blood flow imaging. Neurosurgery. 1996 Aug; 39(2):426-30; discussion 430-1. Ko D, Heck C, Grafton S, Apuzzo ML, Couldwell WT, Chen T, Day JD, Zelman V, Smith T, DeGiorgio CM. PMID: 8832691.
    View in: PubMed Mentions: 25 Fields:
    Translation:Humans
  63. Neuron-specific enolase, a marker of acute neuronal injury, is increased in complex partial status epilepticus. Epilepsia. 1996 Jul; 37(7):606-9. DeGiorgio CM, Gott PS, Rabinowicz AL, Heck CN, Smith TD, Correale JD. PMID: 8681891.
    View in: PubMed Mentions: 23 Fields:
    Translation:Humans
  64. Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen. Clin Cancer Res. 1996 Apr; 2(4):619-22. Couldwell WT, Hinton DR, Surnock AA, DeGiorgio CM, Weiner LP, Apuzzo ML, Masri L, Law RE, Weiss MH. PMID: 9816211.
    View in: PubMed Mentions: 35 Fields:
    Translation:HumansCTClinical Trials
  65. Neuron-specific enolase is increased after single seizures during inpatient video/EEG monitoring. Epilepsia. 1996 Feb; 37(2):122-5. Rabinowicz AL, Correale J, Boutros RB, Couldwell WT, Henderson CW, DeGiorgio CM. PMID: 8635421.
    View in: PubMed Mentions: 11 Fields:
    Translation:Humans
  66. Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease. Neurosurgery. 1995 Jun; 36(6):1112-6; discussion 1116-7. Sutton JP, Couldwell W, Lew MF, Mallory L, Grafton S, DeGiorgio C, Welsh M, Apuzzo ML, Ahmadi J, Waters CH. PMID: 7643989.
    View in: PubMed Mentions: 10 Fields:
    Translation:Humans
  67. Serum neuron-specific enolase in human status epilepticus. Neurology. 1995 Jun; 45(6):1134-7. DeGiorgio CM, Correale JD, Gott PS, Ginsburg DL, Bracht KA, Smith T, Boutros R, Loskota WJ, Rabinowicz AL. PMID: 7783877.
    View in: PubMed Mentions: 30 Fields:
    Translation:Humans
  68. Limited efficacy of experimental anti-epileptic drugs in refractory temporal lobe epilepsy: implications for patient management and study recruitment. Seizure. 1995 Jun; 4(2):135-8. DeGiorgio CM, Couldwell WT, Henderson C, Rabinowicz AL. PMID: 7670765.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  69. Status epilepticus induced by Felbatol withdrawal. Neurology. 1995 May; 45(5):1021-2. DeGiorgio CM, Lopez JE, Lekht ZN, Rabinowicz AL. PMID: 7746379.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  70. Neuron-specific enolase is increased after nonconvulsive status epilepticus. Epilepsia. 1995 May; 36(5):475-9. Rabinowicz AL, Correale JD, Bracht KA, Smith TD, DeGiorgio CM. PMID: 7614925.
    View in: PubMed Mentions: 15 Fields:
    Translation:Humans
  71. CSF neuron-specific enolase after methohexital activation during electrocorticography. Neurology. 1994 Jun; 44(6):1167-9. Rabinowicz AL, Correale JD, Couldwell WT, DeGiorgio CM. PMID: 8208418.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  72. Increasing plasma concentration tolerability study of flunarizine in comedicated epileptic patients. Epilepsia. 1993 Sep-Oct; 34(5):944-53. Treiman DM, Pledger GW, DeGiorgio C, Tsay JY, Cereghino JJ. PMID: 8404751.
    View in: PubMed Mentions: 4 Fields:
    Translation:HumansCTClinical Trials
  73. Hippocampal pyramidal cell loss in human status epilepticus. Epilepsia. 1992 Jan-Feb; 33(1):23-7. DeGiorgio CM, Tomiyasu U, Gott PS, Treiman DM. PMID: 1733757.
    View in: PubMed Mentions: 36 Fields:
    Translation:HumansCells
  74. Compulsive polydipsia following meningioma resection: an epileptic phenomenon? Case report. J Neurosurg. 1991 Nov; 75(5):798-9. Rabinowicz AL, Weiss MH, DeGiorgio CM. PMID: 1919707.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  75. Unruptured intracranial aneurysms: seizures and antiepileptic drug treatment following surgery. J Neurosurg. 1991 Sep; 75(3):371-3. Rabinowicz AL, Ginsburg DL, DeGiorgio CM, Gott PS, Giannotta SL. PMID: 1869935.
    View in: PubMed Mentions: 6 Fields:
    Translation:Humans
  76. Ethical issues in fetal tissue transplants. Linacre Q. 1991 Aug; 58(3):12-32. Rae SB, DeGiorgio CM. PMID: 11652847.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  77. Early prognosis in anoxic coma: an analysis of the major clinical criteria. Issues Law Med. 1989; 5(2):141-64. DeGiorgio CM, Shewmon DA. PMID: 2621088.
    View in: PubMed Mentions: Fields:
    Translation:Humans

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs